Home Page |
References | OMIM | Gene | GeneReviews | HGMD | HGNC |
GENATLAS PHENOTYPE |
last update : 13/06/2006 |
Symbol | ARMS |
Location | 1p36.13 or 2q36.1 and 13q14.11 |
Name | alveolar rhabdomyosarcoma |
Corresponding gene | PAX7 , PAX3 , FOXO1 |
Other symbol(s) | RMS2, RMSA |
Main clinical features |
|
Genetic determination | |
Function/system disorder | neoplasia |
Type | malignancy |
Gene product |
Name | fusion transcripts PAX3-FKHR and PAX7-FKHR |
Mechanism(s) |
Gene mutation | Chromosome rearrangement | Effect | Comments | |
---|---|---|---|---|
translocation | other | acquired t(2;13)(q35;q14), most common with frequent genomic amplification | ||
translocation | other | acquired t(1;13)(p36;q14)less frequent and rarely amplified | ||
other | double minutes (dm)with amplification of MDM, SAS, CDK4 genes | |||
other | MYCN amplification |
Remark(s) | 20 percent without detectable characteristic fusion transcripts |
Genotype/Phenotype correlations | expression of PAX3-FKHR and PAX7-FKHR identifies a very high-risk subgroup and a favorable outcome subgroup, respectively, among patients presenting with metastatic ARMS. A non-coding RNA (NCRMS) may differentiate two subtypes of rhabdomyosarcoma |